Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Next-generation epidermal patches: Bridging 3D and multidimensional printing for biomedical and personal care innovations

El-Khordagui LK., El-Habashy SE., Simchi A., Tohamy HS., Focarete ML., Rea M.

Narrative Review on Chronic Wound, published in Bioact Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Bioact Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42005999
PMCID
PMC13091155
DOI
10.1016/j.bioactmat.2026.03.054

Abstract (original English)

Advances in additive manufacturing, particularly 3D and multidimensional printing, have enabled unprecedented control over the architecture, composition, and bioactivity of epidermal patches. These developments have broadened the scope of epidermal patches across biomedical and personal-care applications, supporting personalized and adaptive solutions for drug delivery, wound management, tissue regeneration, and skin-related interventions. This review summarizes next-generation printed epidermal patches, covering both conventional (non-microneedle) systems and microneedle-integrated platforms. Particular emphasis is placed on emerging material systems, including self-oxygenating hydrogels, nanomaterial-free bioinks derived from proteins and polysaccharides, and functional nanocomposite formulations. We examine key 3D printing strategies for fabricating acellular constructs, cell-laden matrices, and microneedle array patches (MAPs), alongside recent advances in multidimensional printing technologies. Biomedical applications are discussed with a focus on dermal and transdermal drug delivery, particularly insulin delivery for diabetes management as well as wound repair, regenerative therapies, photodynamic treatments, and biosensing. Additionally, the integration of printed epidermal patches with wearable sensors, smart devices, and artificial intelligence (AI) is highlighted as a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research